Relationship between Ailang USA and Shandong Weigao

The relationship between Ailang and Shandong Weigao is that Ailang was acquired by Shandong Weigao in early 2018, which is one of the leading medical device companies in China (HK01066, share price: HK$10.84, market capitalization: HK$49.022 billion). This acquisition is regarded as a typical case of domestic enterprises knocking on the door of overseas market through cross-border M&A of high-quality assets, and Ailang Medical can also expand its business to second- and third-tier cities in China with the help of the existing sales and marketing network of Weigao.